Alnylam Pharmaceuticals Newsroom

TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $371

Futu NewsNov 19 16:36 · Ratings

Express News | Piper Sandler maintains the target price of Alnylam Pharmaceuticals at $296.00.

BreakingsNov 19 02:13

Alnylam Pharmaceuticals Price Target Maintained With a $296.00/Share by Piper Sandler

Dow JonesNov 19 02:10 · Ratings

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study

Zacks Nov 18 21:35

TD Cowen Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TipRanksNov 18 20:36 · Ratings

U.S. stock market opportunities | Transitioning to nasdaq? palantir has surged nearly three times this year, with stock prices reaching new highs; the cryptos craze continues! The exchange Coinbase skyrocketed nearly 10% overnight.

The Ministry of Finance has canceled the tax refund! The cancellation of tax refunds for aluminum products has caused aluminum prices to soar, and alcoa's stock price has reached a new high in a year.

Futu NewsNov 18 18:34

Alnylam Pharmaceuticals Says Nucresiran Performed Well in Phase 1 Transthyretin Amyloidosis Study

MT NewswiresNov 18 16:42

Express News | Alnylam Announces Interim Phase 1 Data of Nucresiran (Aln-Ttrsc04) Showing Rapid Knockdown of Ttr That Is Sustained at Six Months Following a Single Dose

BreakingsNov 17 22:30

Alnylam Downgraded at Wolfe on Doubts Over Amvuttra Growth

Seeking AlphaNov 13 00:22 · Ratings

Alnylam Pharmaceuticals To Present At UBS Global Healthcare Conference; Webcast At 11:45 AM ET

RTTNewsNov 12 23:48

The 3.7% Return This Week Takes Alnylam Pharmaceuticals' (NASDAQ:ALNY) Shareholders Five-year Gains to 202%

Simply Wall StNov 12 20:22

This Airbnb Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

BenzingaNov 12 19:51

Wolfe Research Downgrades Alnylam Pharmaceuticals(ALNY.US) to Sell Rating, Announces Target Price $205

Futu NewsNov 12 06:32 · Ratings

Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks

BenzingaNov 9 03:35

Express News | Alnylam Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $178 From $180

BreakingsNov 6 19:07

Alnylam to Webcast Presentations at Upcoming November Investor Conferences

BusinesswireNov 4 21:00

H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400

Futu NewsNov 4 19:31 · Ratings

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

BenzingaNov 4 19:16 · Ratings

A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $275 to $371

Futu NewsNov 2 21:00 · Ratings

Barclays Maintains Overweight on Alnylam Pharmaceuticals, Raises Price Target to $329

BenzingaNov 1 21:46 · Ratings